Shih-Ting Tsao

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction

Lung-Ji Chang, M. Uiprasertkul, Jatuporn Sujjitjoon, 2020, Translational oncology.

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, Shih-Ting Tsao, Huyong Zheng, 2016 .

Sequential allogeneic and autologous CAR-T-cell therapy to treat an immune-compromised leukemic patient.

Lung-Ji Chang, Shih-Ting Tsao, Xiaochuan Chen, 2018, Blood advances.

HMG‐CoA reductase inhibitors activate caspase‐1 in human monocytes depending on ATP release and P2X7 activation

Wan-Wan Lin, Kuo-Chin Huang, Shih-Ting Tsao, 2013, Journal of leukocyte biology.

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

Lung-Ji Chang, Shih-Ting Tsao, Zhaoxia Zhang, 2017 .

A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count

Shih-Ting Tsao, Hong-Ming Hu, Feng He, 2022, Journal of translational medicine.

Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15Rα Signaling.

Lung-Ji Chang, Wei Zhu, Shih-Ting Tsao, 2019, Current gene therapy.